Australia markets closed

HCA Healthcare, Inc. (HCA)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
187.24-4.26 (-2.22%)
At close: 04:00PM EDT
187.23 -0.01 (-0.01%)
After hours: 07:35PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 54.97B
Enterprise value 94.81B
Trailing P/E 9.25
Forward P/E 9.89
PEG ratio (5-yr expected) 0.95
Price/sales (ttm)0.99
Price/book (mrq)N/A
Enterprise value/revenue 1.58
Enterprise value/EBITDA 6.84

Trading information

Stock price history

Beta (5Y monthly) 1.73
52-week change 3-25.64%
S&P500 52-week change 3-16.03%
52-week high 3279.02
52-week low 3164.47
50-day moving average 3205.90
200-day moving average 3224.55

Share statistics

Avg vol (3-month) 31.52M
Avg vol (10-day) 31.48M
Shares outstanding 5287.02M
Implied shares outstanding 6N/A
Float 8214.3M
% held by insiders 125.07%
% held by institutions 167.35%
Shares short (30 Aug 2022) 43.95M
Short ratio (30 Aug 2022) 43.65
Short % of float (30 Aug 2022) 41.84%
Short % of shares outstanding (30 Aug 2022) 41.38%
Shares short (prior month 28 July 2022) 43.56M

Dividends & splits

Forward annual dividend rate 42.24
Forward annual dividend yield 41.17%
Trailing annual dividend rate 32.08
Trailing annual dividend yield 31.09%
5-year average dividend yield 4N/A
Payout ratio 410.04%
Dividend date 329 Sept 2022
Ex-dividend date 414 Sept 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 June 2022


Profit margin 10.83%
Operating margin (ttm)15.57%

Management effectiveness

Return on assets (ttm)11.73%
Return on equity (ttm)2,259.57%

Income statement

Revenue (ttm)60.1B
Revenue per share (ttm)196.75
Quarterly revenue growth (yoy)2.70%
Gross profit (ttm)22.49B
Net income avi to common (ttm)6.51B
Diluted EPS (ttm)20.71
Quarterly earnings growth (yoy)-20.30%

Balance sheet

Total cash (mrq)973M
Total cash per share (mrq)3.39
Total debt (mrq)40.7B
Total debt/equity (mrq)N/A
Current ratio (mrq)1.55
Book value per share (mrq)-12.82

Cash flow statement

Operating cash flow (ttm)7.7B
Levered free cash flow (ttm)2.8B